Continuous dopamine-receptor stimulation in advanced Parkinson's disease

被引:134
|
作者
Nutt, JG [1 ]
Obeso, JA
Stocchi, F
机构
[1] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[2] Univ Navarra, Dept Neurol, E-31080 Pamplona, Spain
[3] Univ La Sapienza, Prima Clin Neurol, I-00185 Rome, Italy
关键词
D O I
10.1016/S1471-1931(00)00029-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent or pulsatile dopamine-receptor stimulation is postulated to induce plastic changes in motor systems that are responsible for the development of the motor fluctuations and dyskinesia that complicate long-term L-dopa therapy of Parkinson's disease. As a corollary to this hypothesis, continuous dopamine-receptor stimulation can avoid or reverse these complications. Such continuous stimulation is unlikely to mimic completely the normal function of the dopaminergic system, but should avoid the supra-physiological swings in extracellular dopamine that accompany intermittent L-dopa dosing. The concern is that this continuous stimulation might induce tolerance rather than sensitization to some effects of L-dopa. Open clinical trials support the value of continuous dopaminergic stimulation in Parkinson's disease with established motor complications, but rigorous studies, although experimentally difficult, are needed.
引用
收藏
页码:S109 / S115
页数:7
相关论文
共 50 条
  • [41] Are Dopamine Receptor Agonists Neuroprotective in Parkinson’s Disease?
    Wei-Dong Le
    Joseph Jankovic
    Drugs & Aging, 2001, 18 : 389 - 396
  • [42] Dopamine receptor agonists in the therapy of Parkinson’s disease
    P. Foley
    M. Gerlach
    K. L. Double
    P. Riederer
    Journal of Neural Transmission, 2004, 111 : 1375 - 1446
  • [43] Dopamine receptor agonists and depression in Parkinson's disease
    Picillo, Marina
    Rocco, Mariangela
    Barone, Paolo
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S81 - S84
  • [44] Are dopamine receptor agonists neuroprotective in Parkinson's disease?
    Le, WD
    Jankovic, J
    DRUGS & AGING, 2001, 18 (06) : 389 - 396
  • [46] Dopamine receptor agonists in the therapy of Parkinson's disease
    Foley, P
    Gerlach, M
    Double, KL
    Riederer, P
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (10-11) : 1375 - 1446
  • [47] An Approach to the Continuous Dopaminergic Stimulation in Parkinson's Disease
    Schwartz, Miguel
    Sabetay, Sergiu
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2012, 14 (03): : 175 - 179
  • [48] Continuous dopaminergic stimulation in Parkinson's disease treatment
    Stocchi, F
    NEUROLOGIA, 2002, 17 : 62 - 65
  • [49] Managing Parkinson's disease with continuous dopaminergic stimulation
    Wolters, Erik
    Lees, Andrew J.
    Volkmann, Jens
    van Laar, Teus
    Hovestadt, Ad
    CNS SPECTRUMS, 2008, 13 (04) : 1 - 15
  • [50] Continuous subcutaneous apomorphine in advanced Parkinson's disease patients treated with deep brain stimulation
    Sesar, Angel
    Fernandez-Pajarin, Gustavo
    Ares, Begona
    Relova, Jose-Luis
    Aran, Eduardo
    Rivas, Maria-Teresa
    Gelabert-Gonzalez, Miguel
    Castro, Alfonso
    JOURNAL OF NEUROLOGY, 2019, 266 (03) : 659 - 666